Effect of PEEP and Trendelenburg on Ultrasound Size of Internal Jugular and Subclavian Veins (PEEPUS)

December 2, 2016 updated by: University Hospital, Clermont-Ferrand

Effect of PEEP and Trendelenburg on Ultrasound Size of Internal Jugular and Subclavian Veins: A Cross-over Randomized Controlled Study

There is no recommendation for the management of the positive end-expiratory pressure (PEEP) during setting of a central venous catheter (CVC) in a ventilated patient. Several non-randomized studies have investigated the cross-sectional area (AST) ultrasound minor axis for different pressure levels by evaluating a single vessel every time or by not displaying the right or left side in the evaluation. Another study showed that there could be unpredictable size differences between the 2 subclavian veins.

In ventilated patient, the PEEP, which is intrathoracic, will result in a decrease of venous return and thus possibly a superior vena cava dilation, located outside the pleura, depending on their capacitance. Different pressure levels showed an increase of AST with the increase of intra-thoracic pressure on certain veins, in a heterogeneous and not randomized manner.

The primary purpose of the study is to measure the effect of PEEP (0, 5, 10 or 15 cm H2O) and the patient's position (supine or Trendelenburg strict -15-20 °) on the cross-sectional area of the jugular and subclavian veins.

Study Overview

Detailed Description

There is no recommendation for the management of the positive end-expiratory pressure (PEEP) during setting of a central venous catheter (CVC) in a ventilated patient. Several non-randomized studies have investigated the cross-sectional area (AST) ultrasound minor axis for different pressure levels by evaluating a single vessel every time or by not displaying the right or left side in the evaluation. Another study showed that there could be unpredictable size differences between the 2 subclavian veins.

In ventilated patient, the PEEP, which is intrathoracic, will result in a decrease of venous return and thus possibly a superior vena cava dilation, located outside the pleura, depending on their capacitance. Different pressure levels showed an increase of AST with the increase of intra-thoracic pressure on certain veins, in a heterogeneous and not randomized manner.

The primary purpose of the study is to measure the effect of PEEP (0, 5, 10 or 15 cm H2O) and the patient's position (supine or Trendelenburg strict -15-20 °) on the cross-sectional area of the jugular and subclavian veins.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clermont-Ferrand, France, 63003
        • Chu Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Any patient ventilated in intensive care is eligible.
  • Age ≥ 18 years
  • Patient with stable hemodynamic status and Mean Blood Pressure (< 65 mmHg)
  • Patient with registered social security number

Exclusion Criteria:

  • clinical sign for a central venous thrombosis (unilateral edema ...).during echography screening before inclusion
  • presence of a central line for more than 48 hours.
  • Anechoic patient (checked during echography screening)
  • History of cervical spine surgery.
  • IntraCranial HyperTension
  • patient in shock with hemodynamic instability and not stabilized
  • patient treated by noradrenaline > 1 µg/kg/min
  • patient or relative's refusal
  • protected patients ≥ 18 years, minors, pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ventilated patients
Patient's position (Supine or Trendelenburg strict -20°)
Supine or Trendelenburg strict -20°)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The cross-sectional area of the jugular veins ( in cm2)
Time Frame: at baseline
The cross-sectional area of the jugular veins ( in cm2) at the end of the intervention
at baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The cross-sectional area of the subclavian veins ( in cm2)
Time Frame: at baseline
The cross-sectional area of the subclavian veins ( in cm2) at the end of the intervention
at baseline
The antero-posterior diameter of the jugular veins (in mm)
Time Frame: at baseline
The antero-posterior diameter of the jugular veins (in mm) at the end of the intervention
at baseline
The antero-posterior diameter of the subclavian veins (in mm)
Time Frame: at baseline
The antero-posterior diameter of the subclavian veins (in mm) at the end of the intervention
at baseline
The distance between posterior and pleural lining of the jugular veins (in mm)
Time Frame: at baseline
The distance between posterior and pleural lining of the jugular veins (in mm) at the end of the intervention
at baseline
The distance between posterior and pleural lining of the subclavian veins (in mm)
Time Frame: at baseline
The distance between posterior and pleural lining of the subclavian veins (in mm) at the end of the intervention
at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2015

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

September 24, 2015

First Submitted That Met QC Criteria

October 5, 2015

First Posted (Estimate)

October 6, 2015

Study Record Updates

Last Update Posted (Estimate)

December 5, 2016

Last Update Submitted That Met QC Criteria

December 2, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CHU-0246
  • 2015-A00606-43 (Registry Identifier: 2015-A00606-43)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ventilated Patient in Intensive Care

Clinical Trials on Patient's position

3
Subscribe